Sodium–glucose cotransporter 2 inhibitors for treating diabetes mellitus

Nicola Goldberg,M. Fralick
DOI: https://doi.org/10.1503/cmaj.161455
2017-05-23
Canadian Medical Association Journal
Abstract:Sodium–glucose cotransporter 2 inhibitors (SGLT2s) are typically prescribed as a second-line agent for adults with type 2 diabetes mellitus to improve glycemic control. They reduce tubular glucose reabsorption in the proximal tubule, thereby enhancing execretion of urinary glucose. This insulin -
What problem does this paper attempt to address?